Search Results - "Bidot, Carlos J."

Antiphospholipid antibodies: paradigm in transition by Horstman, Lawrence L, Jy, Wenche, Bidot, Carlos J, Ahn, Yeon S, Kelley, Roger E, Zivadinov, Robert, Maghzi, Amir H, Etemadifar, Masoud, Mousavi, Seyed Ali, Minagar, Alireza

“…This is a critical review of anti-phospholipid antibodies (aPL). Most prior reviews focus on the aPL syndrome (APS), a thrombotic condition often marked by…”
Get full text

Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study by Bidot, Carlos J, Horstman, Lawrence L, Jy, Wenche, Jimenez, Joaquin J, Bidot, Jr, Carlos, Ahn, Yeon S, Alexander, J Steven, Gonzalez-Toledo, Eduardo, Kelley, Roger E, Minagar, Alireza

“…The presence of antiphospholipid antibodies (APLA) in multiple sclerosis (MS) patients has been reported frequently but no clear relationship between APLA and…”
Get full text

Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission by Bidot, Carlos J., Jy, Wenche, Horstman, Lawrence L., Ahn, Eugene R., Jimenez, Joaquin J., Yaniz, Miriam, Lander, Gabriela, Ahn, Yeon S.

“…Summary Although the presence of antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) has been reported, their clinical significance is…”
Get full text

Factor VII/VIIa: a new antigen in the anti‐phospholipid antibody syndrome by Bidot, Carlos J., Jy, Wenche, Horstman, Lawrence L., Huisheng, Huang, Jimenez, Joaquin J., Yaniz, Miriam, Ahn, Yeon S.

“…We investigated antibodies to factor VII/VIIa (FVII/VIIa) and five other common target antigens in 33 patients with a history of anti‐phospholipid syndrome…”
Get full text

Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts by Ahn, Eugene R, Tiede, Maike P, Jy, Wenche, Bidot, Carlos J, Fontana, Vincenzo, Ahn, Yeon S

“…It has been suggested that Helicobacter pylori eradication often increases platelet counts in patients with chronic idiopathic thrombocytopenic purpura (ITP)…”
Get more information

Neuromonitoring with microdialysis in severe traumatic brain injury patients by Sanchez, Jose J, Bidot, Carlos J, O'Phelan, Kristine, Gajavelli, Shyam, Yokobori, Shoji, Olvey, Stephen, Jagid, Jonathan, Garcia, Jose Alberto, Nemeth, Zsuzsanna, Bullock, Ross

“…Neuromonitoring with microdialysis has the potential for early detection of metabolic derangements associated with TBI. 1,260 microdialysis samples from 12 TBI…”
Get more information

Cell-derived microparticles and exosomes in neuroinflammatory disorders by Horstman, Lawrence L, Jy, Wenche, Minagar, Alireza, Bidot, Carlos J, Jimenez, Joaquin J, Alexander, J Steven, Ahn, Yeon S

“…All blood cells and the vascular endothelium shed microparticles (MP) from their plasma membranes when suitably stimulated, and assay of MP in patient blood…”
Get full text

Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies by Jy, Wenche, Tiede, Maike, Bidot, Carlos J, Horstman, Lawrence L, Jimenez, Joaquin J, Chirinos, Julio, Ahn, Yeon S

“…Abstract Background Anti-phospholipid antibodies (APLA) are often associated with thrombosis, defining the antiphospholipid syndrome (APS) but it remains…”
Get full text

Potential roles of cell-derived microparticles in ischemic brain disease by Horstman, Lawrence L., Jy, Wenche, Bidot, Carlos J., Nordberg, Mary L., Minagar, Alireza, Alexander, J. Steven, Kelley, Roger E., Ahn, Yeon S.

“…Purpose: The objective of this study is to review the role of cell-derived microparticles in ischemic cerebrovascular diseases. Materials and methods: An…”
Get full text

Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS) by Bidot, Carlos J., Jy, Wenche, Horstman, Lawrence L., Ahn, Eugene R., Yaniz, Miriam, Ahn, Yeon S.

“…Antiphospholipid antibodies (APLA) are associated with anti‐phospholipid syndrome (APS), a thrombotic disorder, but they are also frequently detected in immune…”
Get full text

Differences of soluble CD40L in sera and plasma: Implications on CD40L assay as a marker of thrombotic risk by Ahn, Eugene R, Lander, Gabriella, Jy, Wenche, Bidot, Carlos J, Jimenez, Joaquin J, Horstman, Lawrence L, Ahn, Yeon S

“…Introduction: Soluble CD40L (sCD40L) ELISA has emerged as a promising predictor of poor outcomes in acute coronary syndrome. Yet many blood processing…”
Get full text

Long‐term remission from life‐threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy by Ahn, Eugene R., Lander, Gabriella, Bidot, Carlos J., Jy, Wenche, Ahn, Yeon S.

“…Rituximab, a chimeric monoclonal CD20 antibody, is useful in the treatment of B‐cell lymphomas and certain autoimmune diseases. We report a successful outcome…”
Get full text

Bilateral ballism following streptococcal infection, associated with psychiatric disorder and purpura by Gomez, Antonio N, Diaz-Novas, Jose, Bidot, Carlos J

“…A woman in her 30s was brought to the hospital with abnormal movements. Three months prior, the patient had exacerbation of the movements after an episode of…”
Get full text

Life-threatening hypercoagulable state following splenectomy in ITP: successful management with aggressive antithrombotic therapy and danazol by Tiede, Maike P, Ahn, Eugene R, Jy, Wenche, Scagnelli, Thomas, Bidot, Carlos J, Horstman, Lawrence L, Jimenez, Joaquin J, Ahn, Yeon S

“…A life-threatening hypercoagulable state (HCS) is reported that developed after splenectomy in idiopathic thrombocytopenic purpura (ITP). A 50-year-old active…”
Get more information

Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia by Bidot, Carlos J, Jy, Wenche, Horstman, Lawrence L, Ahn, Eugene R, Bidot, Loreta, Fontana, Vincenzo, Ahn, Yeon S

“…Risk factors for thrombosis (TB) in thrombocythaemia (TC) associated with myeloproliferative disorder (MPD) are not well defined. We measured antiphospholipid…”
Get more information

Endothelial Microparticles (EMP) as Vascular Disease Markers by Jimenez, Joaquin J., Jy, Wenche, Mauro, Lucia M., Horstman, Laurence L., Bidot, Carlos J., Ahn, Yeon S.

“…Endothelial cells (ECs) have long been implicated in the pathogenesis and pathophysiology of a myriad of vascular, thrombotic, and inflammatory disorders. The…”
Get full text

Evidence for Anti-Fibrinolytic Activity of Red Cell-Derived Microparticles (RMP): A Novel Hemostatic Action of RMP by Azad, Mazieyar, Jy, Wenche, Horstman, Lawrence L, Bidot, Carlos J, Gonzalez, Martha, Ahn, Yeon S

“…BACKGROUND. RMP have been developed as novel hemostatic agents for treatment of bleeding disorders [Thromb Haemost 110:751,2013]. RMP generate thrombin in…”
Get full text

Red Cell-Derived Microparticles (RMP) As Hemostatic Agent: Evaluation in a Rabbit Ear Bleeding Model by Jy, Wenche, Bidot, Carlos J, Nunez, Sandra, Johansen, Max E, Horstman, Lawrence L, Ahn, Yeon S

“…Abstract 2238 We are developing RMP for use as an infusible hemostatic agent to treat bleeding conditions. Preliminary evaluations in vitro, such as by…”
Get full text

Release of Microparticles During Blood Storage Is Influenced by Residual Platelets, Leukocytes and Oxygen Levels by Jy, Wenche, Bidot, Carlos J, Yoshida, Tatsuro, Vassallo, Ralph, Johansen, Max E, Horstman, Lawrence L, Morgan, John, Gomez-Marin, Orlando, Shariatmadar, Sherry, Ahn, Yeon S

“…Abstract 3435 Packed red blood cells in blood bank undergo a series of changes and this so-called “storage lesions” increases with time. It is believed that…”
Get full text

Elevated Cholinesterase Activity in Patients with TIA and Other Thrombotic Disorders by Horstman, Larry Lawrence, Ahn, Yeon-Soong, Esquenazi, Jacob, Jy, Wenche, Bidot, Carlos J, Ortega, Camile

“…Abstract 2991 Poster Board II-967 The natural function of ACTH in blood is not well defined. However elevated plasma level was reported in patients with…”
Get full text